Are we getting any better at staying better? The long view on relapse and recovery in first episode nonaffective psychosis and schizophrenia
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Relapse in, and recovery from, schizophrenia has been acknowledged since the disease was first described. In this review the authors summarize the long-term (>100 years) data on relapse and recovery in schizophrenia by reviewing the extant older and modern relevant literature. The authors systematically question the utility of pharmacological and nonpharmacological interventions, with an emphasis on first episode nonaffective psychosis. The method used is a narrative review of earlier meta-analytic and systematic reviews. Antipsychotic medication discontinuation studies suggest a role for prophylactic maintenance treatment in the majority of people with schizophrenia, despite recent debate on this subject. The authors conclude that long-term outcomes, including relapse and recovery rates, have improved in the last 100 years, though prospectively identifying those people who do not require long-term antipsychotic treatment has not yet been possible. Data also suggests that interventions and outcomes during the first 5 years of the disease can influence the long-term schizophrenia trajectory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, neurobehavioural disorders tend to be chronic and relapse even after a positive response to treatment in the short term.20,21”
From Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders (2021) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Andreasen, N. C., Carpenter, W. T., Kane, J. M., Lasser, R. A., Marder, S. R., & Weinberger, D. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.441 · Cited by 2,343
A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes
Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10060855 · Cited by 1,693
Howes, O. D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., Birnbaum, M. L., Bloomfield, M. A. P., Bressan, R. A., Buchanan, R. W., Carpenter, W. T., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050503 · Cited by 1,132
Recovery from psychotic illness: A 15- and 25-year international follow-up study
Harrison, G., Hopper, K., Craig, T., Laska, E., Siegel, C., Wanderling, J., Dube, K. C., Ganev, K., Giel, R., Der Heiden, W. A., et al. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.6.506 · Cited by 1,030
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931
A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
Jaaskelainen, E., Juola, P., Hirvonen, N., McGrath, J. J., Saha, S., Isohanni, M., Veijola, J., & Miettunen, J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs130 · Cited by 907
Review: Suicide and schizophrenia: a systematic review of rates and risk factors
Hor, K., & Taylor, M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385490 · Cited by 853
Self-citationCorrell, C. U., Galling, B., Pawar, A., Krivko, A., Bonetto, C., Ruggeri, M., Craig, T. J., Nordentoft, M., Srihari, V. H., Guloksuz, S., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0623 · Cited by 826
Neuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
One hundred years of schizophrenia: a meta-analysis of the outcome literature
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1409 · Cited by 762
Family intervention for schizophrenia
Pharoah, F., Mari, J., Rathbone, J., & Wong, W. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000088.pub2 · Cited by 737
Csernansky, J. G., Mahmoud, R., & Brenner, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa002028 · Cited by 605
Wunderink, L., Nieboer, R. M., Wiersma, D., Sytema, S., & Nienhuis, F. J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.19 · Cited by 567
Bird, V., Premkumar, P., Kendall, T., Whittington, C., Mitchell, J., & Kuipers, E. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.074526 · Cited by 468
Catamnestic Long-term Study on the Course of Life and Aging of Schizophrenics
Ciompi, L., & Clemens, S. (1980) · Schizophrenia Bulletin · doi:10.1093/schbul/6.4.606 · Cited by 464
Psychosocial Treatments for Schizophrenia
Mueser, K. T., Deavers, F., Penn, D. L., & Cassisi, J. E. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185620 · Cited by 402
Family intervention for schizophrenia
Pharoah, F., Mari, J. J., Rathbone, J., & Wong, W. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000088.pub3 · Cited by 398
Tsuang, M. T. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780120025002 · Cited by 389
Lally, J., Ajnakina, O., Stubbs, B., Cullinane, M., Murphy, K. C., Gaughran, F., & Murray, R. M. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.117.201475 · Cited by 335
What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?
Correll, C. U., Rubio, J. M., & Kane, J. M. (2018) · World Psychiatry · doi:10.1002/wps.20516 · Cited by 324
The Schizophrenic Disorders: Long-Term Patient and Family Studies
LEVIE, C. A. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.7.1001-a · Cited by 298
Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
Olivares, J. M., Sermon, J., Hemels, M., & Schreiner, A. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-32 · Cited by 270
Subotnik, K. L., Casaus, L. R., Ventura, J., Luo, J. S., Hellemann, G. S., Gretchen-Doorly, D., Marder, S., & Nuechterlein, K. H. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0270 · Cited by 262
Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
Morgan, C., Lappin, J., Heslin, M., Donoghue, K., Lomas, B., Reininghaus, U., Onyejiaka, A., Croudace, T., Jones, P. B., Murray, R. M., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291714000282 · Cited by 248
Álvarez-Jiménez, M., Parker, A. G., Hetrick, S. E., McGorry, P. D., & Gleeson, J. F. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp129 · Cited by 245
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Murray, R. M., Quattrone, D., Natesan, S., van Os, J., Nordentoft, M., Howes, O., Di Forti, M., & Taylor, D. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.182683 · Cited by 244
Laws, K. R., Darlington, N., Kondel, T. K., McKenna, P. J., & Jauhar, S. (2018) · BMC Psychology · doi:10.1186/s40359-018-0243-2 · Cited by 234
Self-citationJauhar, S., Nour, M. M., Veronese, M., Rogdaki, M., Bonoldi, I., Azis, M., Turkheimer, F., McGuire, P., Young, A. H., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2943 · Cited by 233
Self-citationA Meta-Analysis of Social Skills Training and Related Interventions for Psychosis
Turner, D. T., McGlanaghy, E., Cuijpers, P., van der Gaag, M., Karyotaki, E., & MacBeth, A. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx146 · Cited by 232
Zipursky, R. B., Menezes, N. M., & Streiner, D. L. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.001 · Cited by 211
Tiihonen, J., Tanskanen, A., & Taipale, H. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17091001 · Cited by 196
Warner, R. (2013) · Routledge eBooks · doi:10.4324/9780203420874 · Cited by 194
The Natural Course of Schizophrenia: A Review of First-admission Studies
Ram, R., Bromet, E. J., Eaton, W. W., Pato, C., & Schwartz, J. E. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.2.185 · Cited by 189
The prognosis in schizophrenia and the factors influencing the course of the disease.
LANGFELDT, G. (1937) · Cited by 182
A Randomized, Controlled Trial of Computer-Assisted Cognitive Remediation for Schizophrenia
Dickinson, D., Tenhula, W., Morris, S., Brown, C., Peer, J., Spencer, K., Li, L., Gold, J. M., & Bellack, A. S. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020264 · Cited by 157
Hui, C. L. M., Honer, W. G., Lee, E. H. M., Chang, W. C., Chan, S. K. W., Chen, E. S. M., Pang, E. P. F., Lui, S. S. Y., Chung, D. W. S., Yeung, W. S., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30090-7 · Cited by 156
Alem, A., Kebede, D., Fekadu, A., Shibre, T., Fekadu, D., Beyero, T., Medhin, G., Negash, A., & Kullgren, G. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn029 · Cited by 129
Wils, R. S., Gotfredsen, D. R., Hjorthøj, C. R., Austin, S. F., Albert, N., Secher, R. G., Thorup, A. A. E., Mors, O. N., & Nordentoft, M. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.030 · Cited by 119
Early risk factors for suicide in an epidemiological first episode psychosis cohort
Dutta, R., Murray, R. M., Allardyce, J., Jones, P. B., & Boydell, J. E. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.11.021 · Cited by 116
Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?
Harrow, M., & Jobe, T. H. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt034 · Cited by 106
Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia
McCutcheon, R., Beck, K., D'Ambrosio, E., Donocik, J., Gobjila, C., Jauhar, S., Kaar, S., Pillinger, T., Reis Marques, T., Rogdaki, M., et al. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12825 · Cited by 102
Self-citationSchizophrenic patients who were never treated – a study in an Indian urban community
PADMAVATHI, R., RAJKUMAR, S., & SRINIVASAN, T. N. (1998) · Psychological Medicine · doi:10.1017/s0033291798007077 · Cited by 99
Ran, M.-S., Weng, X., Chan, C. L.-W., Chen, E. Y.-H., Tang, C.-P., Lin, F.-R., Mao, W.-J., Hu, S.-H., Huang, Y.-Q., & Xiang, M.-Z. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.157685 · Cited by 86
Assessing early signs of relapse in psychosis: Review and future directions
Eisner, E., Drake, R., & Barrowclough, C. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2013.04.001 · Cited by 84
Alvarez-Jimenez, M., O’Donoghue, B., Thompson, A., Gleeson, J. F., Bendall, S., Gonzalez-Blanch, C., Killackey, E., Wunderink, L., & McGorry, P. D. (2016) · CNS Drugs · doi:10.1007/s40263-016-0331-x · Cited by 80
Jauhar, S., Veronese, M., Nour, M. M., Rogdaki, M., Hathway, P., Natesan, S., Turkheimer, F., Stone, J., Egerton, A., McGuire, P., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.07.003 · Cited by 75
Self-citationCharzyńska, K., Kucharska, K., & Mortimer, A. (2015) · International Journal of Occupational Medicine and Environmental Health · doi:10.13075/ijomeh.1896.00341 · Cited by 65
Gleeson, J. F. M., Cotton, S. M., Alvarez-Jimenez, M., Wade, D., Gee, D., Crisp, K., Pearce, T., Spiliotacopoulos, D., Newman, B., & McGorry, P. D. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr165 · Cited by 62
Gomar, J. J., Valls, E., Raduà, J., Mareca, C., Tristany, J., Olmo-Romero, F. D., Rebolleda-Gil, C., Álvarez, M. J. L., de Álvaro, F. J., Ovejero, M. R., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv059 · Cited by 57
COURSE AND PROGNOSIS IN SCHIZOPHRENIA
Malamud, W., & Render, N. (1939) · American Journal of Psychiatry · doi:10.1176/ajp.95.5.1039 · Cited by 57
CBT for schizophrenia: a critical viewpoint
Jauhar, S., Laws, K. R., & McKenna, P. J. (2019) · Psychological Medicine · doi:10.1017/s0033291718004166 · Cited by 52
Self-citationA Delphi Approach To Characterising 'Relapse' as Used in Uk Clinical Practice
Burns, T., Fiander, M., & Audini, B. (2000) · International Journal of Social Psychiatry · doi:10.1177/002076400004600308 · Cited by 46
Takeuchi, H., Kantor, N., Uchida, H., Suzuki, T., & Remington, G. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw171 · Cited by 40
Schizophrenia and Related Syndromes
Tzotzoli, P.-M. (2008) · Journal of Mental Health · doi:10.1080/09638230701879243 · Cited by 38
Boonstra, G., Burger, H., Grobbee, D. E., & Kahn, R. S. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2010.534801 · Cited by 38
Emsley, R., Nuamah, I., Gopal, S., Hough, D., & Fleischhacker, W. W. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11874 · Cited by 34
Do antipsychotic drugs lose their efficacy for relapse prevention over time?
Leucht, S., & Davis, J. M. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.117.201103 · Cited by 32
Buonocore, M., Bosia, M., Baraldi, M. A., Bechi, M., Spangaro, M., Cocchi, F., Bianchi, L., Guglielmino, C., Mastromatteo, A. R., & Cavallaro, R. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12605 · Cited by 28
Models to predict relapse in psychosis: A systematic review
Sullivan, S. A., Northstone, K., Gadd, C., Walker, J. S., Margelyte, R., Richards, A., & Whiting, P. F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183998 · Cited by 25
Ahmed, A. O., Marino, B., Rosenthal, E., Buckner, A., Hunter, K. M., Mabe, P. A., & Buckley, P. F. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.01.009 · Cited by 23
Mallet, J., Lancrenon, S., Llorca, P., Lançon, C., Bayle, F., & Gorwood, P. A. P. M. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.09.001 · Cited by 16
Research works printed but not linked: 1
- Kraepelin E. Dementia praecox. Cambridge University Press, 1987.
Cited by
Sampogna, G., Vincenzo, M. D., Giuliani, L., Menculini, G., Mancuso, E., Arsenio, E., Cipolla, S., Rocca, B. D., Martiadis, V., Signorelli, M. S., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13111577 · Cited by 82
New Developments in the Treatment of Schizophrenia: An Expert Roundtable
Kantrowitz, J. T., Correll, C. U., Jain, R., & Cutler, A. J. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad011 · Cited by 57
Lin, D., Joshi, K., Keenan, A., Shepherd, J., Bailey, H. M. L., Berry, M., Wright, J., Meakin, S., Benson, C. J., & Kim, E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.695672 · Cited by 55
Prevalence of treatment resistance and clozapine use in early intervention services
Stokes, I., Griffiths, S. L., Jones, R., Everard, L., Jones, P. B., Fowler, D. G., Hodgekins, J., Amos, T., Freemantle, N., Sharma, V. K., et al. (2020) · BJPsych Open · doi:10.1192/bjo.2020.89 · Cited by 44
Lenze, E. J., Nicol, G. E., Barbour, D. L., Kannampallil, T., Wong, A. W. K., Piccirillo, J., Drysdale, A. T., Sylvester, C. M., Haddad, R., Miller, J. P., et al. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200042 · Cited by 43
Metadata
- Authors
- Taylor, M., & Jauhar, S.
- Affiliations
- The University of Queensland (AU)
- King's College London (GB)
- Corresponding author
- Taylor, Mark
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2019-01
- Volume
- 9
- Pages
- 2045125319870033-2045125319870033
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- PMC
- PMC6732843
- OpenAlex
- W2971922960
- Cited by
- 51
- References
- 62
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 8 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 4 · 2019: 1
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Therapeutic Advances in Psychopharmacology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- schizophrenia, first-episode psychosis, relapse, recovery, long-term outcomes, antipsychotic drugs, antipsychotic discontinuation, non-affective psychosis, treatment outcomes over time
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.